Abstract:Inflammatory bowel disease (IBD) is a formidable disease due to its complex pathogenesis. Macrophages, as a major immune cell population in IBD, are crucial for gut homeostasis. However, it is still unveiled how macrophages modulate IBD. Here, we found that LIM domain only 7 (LMO7) was downregulated in pro-inflammatory macrophages, and that LMO7 directly degraded 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) through K48-mediated ubiquitination in macrophages. As an enzyme that regulates glycolysis, PFKFB3 degradation led to the glycolytic process inhibition in macrophages, which in turn inhibited macrophage activation and ultimately attenuated murine colitis. Moreover, we demonstrated that PFKFB3 was required for histone demethylase Jumonji domain-containing protein 3 (JMJD3) expression, thereby inhibiting the protein level of trimethylation of histone H3 on lysine 27 (H3K27me3). Overall, our results indicated the LMO7/PFKFB3/JMJD3 axis is essential for modulating macrophage function and IBD pathogenesis. Targeting LMO7 or macrophage metabolism could potentially be an effective strategy for treating inflammatory diseases.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the mechanism of LIM domain only 7 (LMO7) in inflammatory bowel disease (IBD). Specifically, the study focuses on how LMO7 affects the function of macrophages through metabolic - epigenetic reprogramming, and then regulates the pathological process of IBD. The study found that LMO7 is down - regulated in pro - inflammatory macrophages, and LMO7 can directly degrade 6 - phosphofructo - 2 - kinase/fructose - 2,6 - bisphosphatase 3 (PFKFB3) through K48 - linked ubiquitination, inhibit the glycolysis process of macrophages, thereby inhibiting the activation of macrophages, and finally alleviating colitis in mice. In addition, the study also shows that PFKFB3 is necessary for the expression of histone demethylase Jumonji domain - containing protein 3 (JMJD3), and promotes gene expression by inhibiting the protein level of H3K27me3. Overall, these results indicate that the LMO7/PFKFB3/JMJD3 axis plays a key role in regulating macrophage function and the pathogenesis of IBD, and targeting LMO7 or macrophage metabolism may be an effective strategy for treating inflammatory diseases.

Macrophage LMO7 deficiency facilitates inflammatory injury via metabolic-epigenetic reprogramming